)
)
Artiva Biotherapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Artiva Biotherapeutics Inc
Access all reports
Artiva Biotherapeutics Inc. is a biotechnology company focused on developing off-the-shelf, allogeneic natural killer (NK) cell therapies for cancer treatment. The company's therapies utilize NK cell technology combined with advanced genetic engineering and proprietary manufacturing processes to enhance the effectiveness of NK cells in targeting cancer cells. Artiva’s therapeutic platforms are designed to address various cancer types, with an emphasis on scalability and accessibility for patients. Its development pipeline covers multiple forms of immunotherapies aimed at both solid tumors and hematologic malignancies. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
ARTV
Country
🇺🇸 United States